Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The goal of this application is to evaluate the safety and efficacy of atorvastatin as a
potential treatment to preserve beta cell function in children and young adults with newly
diagnosed type 1 diabetes (T1DM).
Phase:
Phase 2
Details
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborators:
FDA Office of Orphan Products Development Medical University of South Carolina